The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
SirT1 Regulates Adipose Tissue Inflammation
Abstract
OBJECTIVE: Macrophage recruitment to adipose tissue is a reproducible feature of obesity. However, the events that result in chemokine production and macrophage recruitment to adipose tissue during states of energetic excess are not clear. Sirtuin 1 (SirT1) is an essential nutrient-sensing histone deacetylase, which is increased by caloric restriction and reduced by overfeeding. We discovered that SirT1 depletion causes anorexia by stimulating production of inflammatory factors in white adipose tissue and thus posit that decreases in SirT1 link overnutrition and adipose tissue inflammation. RESEARCH DESIGN AND METHODS: We used antisense oligonucleotides to reduce SirT1 to levels similar to those seen during overnutrition and studied SirT1-overexpressing transgenic mice and fat-specific SirT1 knockout animals. Finally, we analyzed subcutaneous adipose tissue biopsies from two independent cohorts of human subjects. RESULTS: We found that inducible or genetic reduction of SirT1 in vivo causes macrophage recruitment to adipose tissue, whereas overexpression of SirT1 prevents adipose tissue macrophage accumulation caused by chronic high-fat feeding. We also found that SirT1 expression in human subcutaneous fat is inversely related to adipose tissue macrophage infiltration. CONCLUSIONS: Reduction of adipose tissue SirT1 expression, which leads to histone hyperacetylation and ectopic inflammatory gene expression, is identified as a key regulatory component of macrophage influx into adipose tissue during overnutrition in rodents and humans. Our results suggest that SirT1 regulates adipose tissue inflammation by controlling the gain of proinflammatory transcription in response to inducers such as fatty acids, hypoxia, and endoplasmic reticulum stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Reduction of SIRT1 levels correlates with the development and progression of many inflammatory diseases.
“reduction of SIRT1 levels correlates with the development and progression of many inflammatory diseases”
From The Hallmarks of Aging (2013) · cites this paper as Gillum et al., 2011
The Results (Fig. 6; page unavailable) report an inverse correlation between SirT1 expression and macrophage markers in human adipose tissue. The Conclusions (page unavailable) link reduced SirT1 to adipose tissue inflammation during overnutrition. The paper does not establish a correlation with the development or progression of many inflammatory diseases; that extends beyond the condition studied. (LLM, conf=0.88)
Experimental — accuracy not yet measuredPharmacologic activation of SIRT1 may prevent inflammatory responses in mice.
“pharmacologic activation of SIRT1 may prevent inflammatory responses in mice”
From The Hallmarks of Aging (2013) · cites this paper as Gillum et al., 2011
The Results section reports that genetic SirT1 overexpression reduced high-fat-diet-induced adipose tissue inflammation in mice. It does not establish that pharmacologic activation has this effect; the paper also cautions that polyphenols used to modify SirT1 function are not direct activators. Its findings are specific to the high-fat-diet setting, while SirT1-overexpressing mice on regular chow showed elevated inflammatory markers. Page numbers are unavailable in our copy. (LLM, conf=0.88)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664
TLR4 links innate immunity and fatty acid-induced insulin resistance
Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S. (2006) · Journal of Clinical Investigation · doi:10.1172/jci28898 · Cited by 3,690
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Nutrient control of glucose homeostasis through a complex of PGC-1α and SIRT1
Rodgers, J. T., Lerin, C., Haas, W., Gygi, S. P., Spiegelman, B. M., & Puigserver, P. (2005) · Nature · doi:10.1038/nature03354 · Cited by 3,160
Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase
Yeung, F., Hoberg, J. E., Ramsey, C. S., Keller, M. D., Jones, D. R., Frye, R. A., & Mayo, M. W. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600244 · Cited by 2,750
Cellular mechanisms of insulin resistance
Shulman, G. I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10583 · Cited by 2,714
Self-citationKanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
IKK-β links inflammation to obesity-induced insulin resistance
Arkan, M. C., Hevener, A. L., Greten, F. R., Maeda, S., Li, Z.-W., Long, J. M., Wynshaw-Boris, A., Poli, G., Olefsky, J., & Karin, M. (2005) · Nature Medicine · doi:10.1038/nm1185 · Cited by 1,773
Self-citationAdipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., et al. (2007) · Diabetes · doi:10.2337/db06-0911 · Cited by 1,257 · cited 1×
“Several potential inducers have been identified, including adipocyte endoplasmic reticulum (ER) stress (6), adipose tissue microhypoxia and hypoxia-inducible factor (HIF)-1a induction (7,8), adipocyte necrosis (2), and fatty acid stimulation of toll-like receptor (TLR) 4 (9), but little is known about how the response…”
BackgroundMechanism of Human SIRT1 Activation by Resveratrol
Borra, M. T., Smith, B. C., & Denu, J. M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501250200 · Cited by 1,065
SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1
Pacholec, M., Bleasdale, J. E., Chrunyk, B., Cunningham, D., Flynn, D., Garofalo, R. S., Griffith, D., Griffor, M., Loulakis, P., Pabst, B., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088682 · Cited by 915
Hypoxia-Inducible Factor 1α Induces Fibrosis and Insulin Resistance in White Adipose Tissue
Halberg, N., Khan, T., Trujillo, M. E., Wernstedt-Asterholm, I., Attie, A. D., Sherwani, S., Wang, Z. V., Landskroner-Eiger, S., Dineen, S., Magalang, U. J., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00192-09 · Cited by 896
Ablation of CD11c-Positive Cells Normalizes Insulin Sensitivity in Obese Insulin Resistant Animals
Patsouris, D., Li, P.-P., Thapar, D., Chapman, J., Olefsky, J. M., & Neels, J. G. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.08.015 · Cited by 804 · cited 2×
“This is consistent with data showing that although “M1” macrophages are disproportionately increased, “M2” macrophages (CD11c-) are also dramatically increased in obese WAT (44).”
BackgroundResultSelf-citationWeight loss and lipolysis promote a dynamic immune response in murine adipose tissue
Kosteli, A., Sugaru, E., Haemmerle, G., Martin, J. F., Lei, J., Zechner, R., & Ferrante, A. W. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42845 · Cited by 726 · cited 1×
“Recent data have also suggested that free fatty acids associated with lipolysis and weight loss can also recruit macrophages to WAT (39).”
Background
Flagged first, then by citations
Research works printed but not linked: 31
- Cinti, 2005, Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans, J Lipid Res, 46, 2347, 10.1194/jlr.M500294-JLR200 · DOI · Paper page
- Sabio, 2008, A stress signaling pathway in adipose tissue regulates hepatic insulin resistance, Science, 322, 1539, 10.1126/science.1160794 · DOI · Paper page
- Ozcan, 2004, Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes, Science, 306, 457, 10.1126/science.1103160 · DOI · Paper page
- Rodgers, 2007, Fasting-dependent glucose and lipid metabolic response through hepatic sirtuin 1, Proc Natl Acad Sci USA, 104, 12861, 10.1073/pnas.0702509104 · DOI · Paper page
- Chen, 2007, SIR2: a potential target for calorie restriction mimetics, Trends Mol Med, 13, 64, 10.1016/j.molmed.2006.12.004 · DOI
- Purushotham, 2009, Hepatocyte-specific deletion of SIRT1 alters fatty acid metabolism and results in hepatic steatosis and inflammation, Cell Metab, 9, 327, 10.1016/j.cmet.2009.02.006 · DOI · Paper page
- Erion, 2009, SirT1 knockdown in liver decreases basal hepatic glucose production and increases hepatic insulin responsiveness in diabetic rats, Proc Natl Acad Sci USA, 106, 11288, 10.1073/pnas.0812931106 · DOI
- Banks, 2008, SirT1 gain of function increases energy efficiency and prevents diabetes in mice, Cell Metab, 8, 333, 10.1016/j.cmet.2008.08.014 · DOI
- Qiao, 2006, SIRT1 regulates adiponectin gene expression through Foxo1-C/enhancer-binding protein alpha transcriptional complex, J Biol Chem, 281, 39915, 10.1074/jbc.M607215200 · DOI
- Ghosh, 2007, Sirt1 interacts with transducin-like enhancer of split-1 to inhibit nuclear factor kappaB-mediated transcription, Biochem J, 408, 105, 10.1042/BJ20070817 · DOI
- Yoshizaki, 2009, SIRT1 exerts anti-inflammatory effects and improves insulin sensitivity in adipocytes, Mol Cell Biol, 29, 1363, 10.1128/MCB.00705-08 · DOI
- Pfluger, 2008, Sirt1 protects against high-fat diet-induced metabolic damage, Proc Natl Acad Sci USA, 105, 9793, 10.1073/pnas.0802917105 · DOI · Paper page
- Kaeberlein, 2005, Substrate-specific activation of sirtuins by resveratrol, J Biol Chem, 280, 17038, 10.1074/jbc.M500655200 · DOI · Paper page
- Vaquero, 2004, Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin, Mol Cell, 16, 93, 10.1016/j.molcel.2004.08.031 · DOI · Paper page
- Liu, 2011, NAD+-dependent SIRT1 deacetylase participates in epigenetic reprogramming during endotoxin tolerance, J Biol Chem, 286, 9856, 10.1074/jbc.M110.196790 · DOI
- Luo, 2010, Macrophage adiponectin expression improves insulin sensitivity and protects against inflammation and atherosclerosis, Diabetes, 59, 791, 10.2337/db09-1338 · DOI
- Cali’, 2008, Metabolic abnormalities underlying the different prediabetic phenotypes in obese adolescents, J Clin Endocrinol Metab, 93, 1767, 10.1210/jc.2007-1722 · DOI
- Burgert, 2006, Alanine aminotransferase levels and fatty liver in childhood obesity: associations with insulin resistance, adiponectin, and visceral fat, J Clin Endocrinol Metab, 91, 4287, 10.1210/jc.2006-1010 · DOI
- Cali, 2009, Glucose dysregulation and hepatic steatosis in obese adolescents: is there a link?, Hepatology, 49, 1896, 10.1002/hep.22858 · DOI
- Sears, 2009, Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization, Proc Natl Acad Sci USA, 106, 18745, 10.1073/pnas.0903032106 · DOI
- Nagai, 2009, The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance, Cell Metab, 9, 252, 10.1016/j.cmet.2009.01.011 · DOI · Paper page
- Matarese, 2004, The intricate interface between immune system and metabolism, Trends Immunol, 25, 193, 10.1016/j.it.2004.02.009 · DOI
- Nie, 2009, STAT3 inhibition of gluconeogenesis is downregulated by SirT1, Nat Cell Biol, 11, 492, 10.1038/ncb1857 · DOI
- Mamane, 2009, The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation, Diabetes, 58, 2006, 10.2337/db09-0323 · DOI
- Kawahara, 2009, SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span, Cell, 136, 62, 10.1016/j.cell.2008.10.052 · DOI · Paper page
- Makris, 2000, Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti, Mol Cell, 5, 969, 10.1016/S1097-2765(00)80262-2 · DOI
- Pasparakis, 2009, Regulation of tissue homeostasis by NF-kappaB signalling: implications for inflammatory diseases, Nat Rev Immunol, 9, 778, 10.1038/nri2655 · DOI
- Savage, 2007, Disordered lipid metabolism and the pathogenesis of insulin resistance, Physiol Rev, 87, 507, 10.1152/physrev.00024.2006 · DOI · Paper page
- Cani, 2007, Metabolic endotoxemia initiates obesity and insulin resistance, Diabetes, 56, 1761, 10.2337/db06-1491 · DOI · Paper page
- Vaziri, 2001, hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase, Cell, 107, 149, 10.1016/S0092-8674(01)00527-X · DOI
- Picard, 2004, Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma, Nature, 429, 771, 10.1038/nature02583 · DOI
Cited by
Sorted by citations
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms
Petrie, J. R., Guzik, T. J., & Touyz, R. M. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.005 · Cited by 1,787
Calorie restriction and sirtuins revisited
Guarente, L. (2013) · Genes & Development · doi:10.1101/gad.227439.113 · Cited by 464
Aging Hallmarks: The Benefits of Physical Exercise
Rebelo-Marques, A., De Sousa Lages, A., Andrade, R., Ribeiro, C. F., Mota-Pinto, A., Carrilho, F., & Espregueira-Mendes, J. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00258 · Cited by 246
‘Adipaging’: ageing and obesity share biological hallmarks related to a dysfunctional adipose tissue
Pérez, L. M., Pareja‐Galeano, H., Sanchis‐Gomar, F., Emanuele, E., Lucia, A., & Gálvez, B. G. (2016) · The Journal of Physiology · doi:10.1113/jp271691 · Cited by 215
Recent advances in obesity-induced inflammation and insulin resistance
Tateya, S., Kim, F., & Tamori, Y. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00093 · Cited by 211
Stromsdorfer, K. L., Yamaguchi, S., Yoon, M. J., Moseley, A. C., Franczyk, M. P., Kelly, S. C., Qi, N., Imai, S.-I., & Yoshino, J. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.027 · Cited by 213
Possible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment
Hwang, E., & Song, S. (2020) · Biomolecules · doi:10.3390/biom10050687 · Cited by 144
SIRT1 signaling as potential modulator of skeletal muscle diseases
Tonkin, J., Villarroya, F., Puri, P. L., & Vinciguerra, M. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.02.010 · Cited by 60
SIRT1 limits adipocyte hyperplasia through c-Myc inhibition
Abdesselem, H., Madani, A., Hani, A., Al-Noubi, M., Goswami, N., Ben Hamidane, H., Billing, A. M., Pasquier, J., Bonkowski, M. S., Halabi, N., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.675645 · Cited by 56
Importance of Adipose Tissue NAD+ Biology in Regulating Metabolic Flexibility
Franczyk, M. P., Qi, N., Stromsdorfer, K. L., Li, C., Yamaguchi, S., Itoh, H., Yoshino, M., Sasaki, Y., Brookheart, R. T., Finck, B. N., et al. (2021) · Endocrinology · doi:10.1210/endocr/bqab006 · Cited by 23
Metadata
- Authors
- Gillum, M. P., Kotas, M. E., Erion, D. M., Kursawe, R., Chatterjee, P., Nead, K. T., Muise, E. S., Hsiao, J. J., Frederick, D. W., Yonemitsu, S., Banks, A. S., Qiang, L., Bhanot, S., Olefsky, J. M., Sears, D. D., Caprio, S., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute, Chevy Chase, Maryland
- Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut
- Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut
- Merck, Rahway, New Jersey
- Department of Cell Biology, Harvard School of Medicine, Boston, Massachusetts
- Columbia University, New York, New York
- Isis Pharmaceuticals, Carlsbad, California
- University of California San Diego, San Diego, California
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2011-11-13
- Volume
- 60
- Issue
- 12
- Pages
- 3235-3245
- ISSN
- 0012-1797
- 1939-327X
- PMC
- PMC3219953
- Cited by
- 260
- References
- 17
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review